Key players in China’s infant formula industry have reported a drop in their gross profit margins in the first six months of this year, including the biggest local player Feihe, as well as Health and Happiness Group (H&H Group), and Ausnutria.
China’s major nutrition brands and suppliers appear to have recovered from the manufacturing and supply chain impact of COVID-19 after reporting better than expected Q3 financials.
Chinese dietary supplement giant BY-HEALTH’s revenue for the first half of 2019 increased by 36.8% year-on-year, despite a slowing e-commerce business and stricter regulatory environment.
Australia supplements giant Blackmores has announced weak Q3 results thanks to slower domestic and China sales, but the firm is confident its new development strategies will get it back on track.
Blackmores' in-market sales in China dipped in the first half of the financial year, causing its shares to slide and emphasising the difficulty in shifting from a daigou-based model to domestic Chinese trade.
The world’s biggest dairy co-operative will review its stake in Chinese formula milk company Beingmate after unveiling the first ever annual loss in its 17-year history.
Infant nutrition firm Bellamy's Organic has announced a 37% year-on-year growth in sales revenue to US$236.1m (A$329m) for the 2018 financial year, up from US$172.3m (A$240m) in 2017.
Blackmores recorded 9% year-on-year revenue growth to A$601.1m for the financial year ending in June, with China and overall Asia sales contributing significantly to this increase.